CUMBERLAND PHARMACEUTICALS INC - 10-Q Filing
Cumberland Pharmaceuticals reports $81.1M gain on disposal of discontinued operations and increased cash position to $80.6M for Q3 2026.
Tickers: $CPIX
More Regulatory news
- Alset Inc. - 10-Q Filing
- Trump Media & Technology Group Corp. - 4 Filing
- PERPETUA RESOURCES CORP. - 10-Q Filing
- Trump Media & Technology Group Corp. - 4 Filing
- Dragonfly Energy Holdings Corp. - 10-Q Filing
- SYNTEC OPTICS HOLDINGS, INC. - 10-Q Filing
- MACROGENICS INC - 8-K Filing
- Trump Media & Technology Group Corp. - 4 Filing
- Canary XRP ETF - 10-Q Filing
- Eightco Holdings Inc. - 10-Q Filing